Target intelligence / Profile preview

RNA, U2 small nuclear 17, pseudogene (RNU2-17P)

Target
RNU2-17P
Molecular classification
Other
01

Overview

"RNA, U2 small nuclear 17, pseudogene" (RNU2-17P) is a member of the U2 small nuclear RNA pseudogene family. U2 small nuclear RNAs (snRNAs) are core components of the major spliceosome, where they play essential roles in recognizing branch points and catalyzing pre-mRNA splicing[1]. However, RNU2-17P is annotated as a pseudogene: it is a DNA sequence similar to the functional U2 snRNA genes but is not known to produce a functional RNA product or participate directly in the spliceosome. Pseudogenes such as RNU2-17P typically arise via gene duplication or retrotransposition events and lack functional activity due to mutations, deletions, or lack of regulatory elements required for expression[2]. There is no evidence that this specific pseudogene encodes a protein, has direct biological function, or is considered a drug target; it also does not have established roles in disease, biomarker utility, or safety concerns. The main functional (not pseudogene) U2 snRNAs are important for splicing and RNA processing, but pseudogenes like RNU2-17P are not targets for therapeutic intervention[1][2][3].

Other names
RNU2-17PU2 snRNA 17 pseudogeneU2 spliceosomal RNA pseudogene 17

Beyond the preview

Go deeper on RNA, U2 small nuclear 17, pseudogene (RNU2-17P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U2 small nuclear 17, pseudogene (RNU2-17P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call